Trials Sponsors Conditions Drugs Pricing

You may not qualify if:

\- Patients who met the following criteria parameters were deemed ineligible and were excluded from the study.
Patients with corneal infection (i.e., fungus, bacteria, virus. Etc.).
The treatment eye had been cataract surgery, pupilloplasty, or the vision or complication is not stabilized post-operation within one month before transplantation.
The treatment eye had received corneal transplantation, other eye surgeries, retinal laser, any kind of invasive eye treatment or drug injection within three months.
Pregnant patients (the urine or blood pregnancy test of woman of childbearing potential\* is positive) or patients who had recently given birth and were nursing the newborn child.
\*：A woman of childbearing potential (WOCBP) is defined as a premenopausal female capable of becoming pregnant. This includes women on oral, injectable, or mechanical contraception; women who are single; women whose husbands have been vasectomized or whose husbands have received or are utilizing mechanical contraceptive devices.
Patients with a hemorrhagic disease (In the patients who is taking Warfarin, the INR is over 3.0.).
Patients who were judged by the attending physicians to be incapable of understanding the procedure or of providing sufficient corporation due to mental retardation or mental disorder.
Glaucoma patients with poor IOP control (Patients with maximum dosage of glaucoma medicines (Prostaglandin analogue, beta-blocker, alpha2 agonist, and carbonic anhydrase inhibitor) or after surgery, the IOP cannot be controlled under 25 mmHg.).
Patients with acute eye infection or inflammation (i.e., bacterial or fungal infection, acute uveitis.)
Diabetic patients with a poor blood-sugar control (Patients with HbA1c \> 10% within the past three months.).
Patients who were hypersensitive to steroids.
Patients with systemic autoimmune disease (i.e., systemic lupus erythematosus, Behcet's disease, etc.)
Patients strongly suspected to have a severe visual disorder due to concomitant other factors.
Patients who had already received this therapy.
+4 more criteria

Cell Therapy for Corneal Endothelial Cell Dysfunction

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

Cell

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

Cell

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations